Discover Affordable Custom NGS Panels
News Feb 12, 2015
Integrated DNA Technologies (IDT) will host an informative webinar entitled ‘Custom, Affordable Gene Panels with Superior Coverage and Uniformity’ on February 18, 2015.
Presented by Rami Zahr, NGS Product Manager at IDT, the webinar will be available at 9am and 1pm Central Standard Time and explain how to design and optimize custom target capture panels at a much lower cost as well as enhance the performance of existing panels.
Off-the-shelf probe pools or panels often do not match a researcher’s experimental needs while custom designed probe pools or panels come at a high cost.
The IDT xGen® Predesigned Gene Capture Pools and Plates are built for highly uniform and specific target capture performance and webinar attendees will learn how they can be used to design and optimize new panels, as well as enhance existing panels, cost-effectively.
Attendees will also be shown how to design their own custom plates and, by mixing probes as needed, build panels to target specific CDS, UTR, introns or intergenic regions. The webinar aims to equip researchers using NGS target capture technologies with the ability to save costs and reduce waste in their work.
Researchers Awarded $28M for Illuminating Druggable Genome NIH GrantsNews
Researchers receive grants as part of the NIH program focused on experimental and informatics approaches to characterize understudied proteins from three gene families: ion channels, G protein-coupled receptors (GPCRs), and protein kinases.READ MORE
No Country for Old GenesNews
Our modern world is radically different from the one we evolved in, and that creates a mismatch between the environment our genes were evolved to face, and the world those genes now encounter. A new review looks at how certain genes that benefited humans in our genetic past now predispose us to disease in old age.READ MORE
CRISPR Editing Stops HIV Virus in Infected CellsNews
Human immunodeficiency virus-1 (HIV-1) infection is a chronic disease affecting more than 35 million people worldwide. The infection can be controlled by antiretroviral therapy (ART), but there is still no complete cure. Now, a new study targeting the regulatory genes of the virus using CRISPR/Cas9 has helped block the production of the virus by infected cells.READ MORE